BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 7338581)

  • 1. Bumetanide in refractory ascites of cirrhosis of the liver: a comparison with furosemide.
    Iber FL; Baum RA
    J Clin Pharmacol; 1981; 21(11):697-700. PubMed ID: 7338581
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A comparison of bumetanide and furosemide in the treatment of ascites. Cooperative study.
    Herlong HF; Hunter FM; Koff RS; Maddrey WC
    J Clin Pharmacol; 1981; 21(11):701-5. PubMed ID: 7338582
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effects of a single, intravenous dose of bumetanide versus furosemide in patients with ascites and edema due to alcoholic liver disease.
    Koff RS
    J Clin Pharmacol; 1981; 21(11):706-11. PubMed ID: 7040497
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical pharmacology of loop diuretics: a comparative study.
    Ansuini R; Pulido M; Pupita G; Gaggi S; Pupita F
    Int J Clin Pharmacol Res; 1985; 5(2):113-21. PubMed ID: 4018941
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of diuretics in the treatment of cirrhotic ascites.
    Boyer TD; Warnock DG
    Gastroenterology; 1983 May; 84(5 Pt 1):1051-5. PubMed ID: 6832557
    [No Abstract]   [Full Text] [Related]  

  • 6. Treatment of fluid retention in cirrhosis: a comparison of bumetanide and frusemide.
    Nicholson G
    Curr Med Res Opin; 1977; 4(9):675-9. PubMed ID: 338256
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bumetanide in the treatment of hepatic ascites.
    Ring-Larsen H
    Postgrad Med J; 1975; 51 Suppl 6():77-81. PubMed ID: 1105536
    [No Abstract]   [Full Text] [Related]  

  • 8. Diuretics in malignant effusions and edemas of generalized cancer.
    Razis DV; Athanasiou A; Dadiotis L
    J Med; 1976; 7(6):449-61. PubMed ID: 1070516
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Clinical evaluation of bumetanide in the diuretic treatment of heart failure and liver cirrhosis].
    Mauro G; Cantino G; Vigiani L
    Clin Ter; 1981 Mar; 96(5):515-21. PubMed ID: 7285521
    [No Abstract]   [Full Text] [Related]  

  • 10. A comparative randomized double-blind clinical trial of bumetanide and furosemide in congestive cardiac failure and other edema states.
    Sagar S; Sharma BK; Sharma PL; Wahi PL
    Int J Clin Pharmacol Ther Toxicol; 1984 Sep; 22(9):473-8. PubMed ID: 6389378
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term bumetanide treatment of renal edema. Comparison with furosemide.
    Whelton A
    J Clin Pharmacol; 1981; 21(11):591-8. PubMed ID: 7040493
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Advantages of the new loop diuretic torasemide over furosemide in patients with cirrhosis and ascites. A randomized, double blind cross-over trial.
    Gerbes AL; Bertheau-Reitha U; Falkner C; Jüngst D; Paumgartner G
    J Hepatol; 1993 Mar; 17(3):353-8. PubMed ID: 8315263
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intramuscular bumetanide and furosemide in congestive heart failure.
    Abrams J
    J Clin Pharmacol; 1981; 21(11):673-9. PubMed ID: 7338578
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Torasemide in the treatment of patients with cirrhosis and ascites.
    Gentilini P; Laffi G; La Villa G; Carloni V; Foschi M; Romanelli RG; Marra F
    Cardiovasc Drugs Ther; 1993 Jan; 7 Suppl 1():81-5. PubMed ID: 8435382
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effectiveness of bumetanide in nephrotic syndrome: a double-blind crossover study with furosemide.
    Lau K; DeFronzo R; Morrison G; Rascoff J; Goldberg M; Agus ZS
    J Clin Pharmacol; 1976 Oct; 16(10 Pt 1):489-97. PubMed ID: 789411
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Bumetanide therapy of cirrhotic ascites. Comparison of different doses and modes of administration].
    Saffiotti O; Balzano A; Rinaldi M; Savarese M; Sito M; Del Vecchio-Blanco C
    Clin Ter; 1983 May; 105(4):281-8. PubMed ID: 6872470
    [No Abstract]   [Full Text] [Related]  

  • 17. Bumetanide, spironolactone and a combination of the two, in the treatment of ascites due to liver disease. A prospective, controlled, randomized trial.
    Sarin SK; Sachdev G; Mishra SP; Sundaram KR; Shrivastwa A; Talukdar V; Broor SL
    Digestion; 1988; 41(2):101-7. PubMed ID: 3065101
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Comparison between torasemide and furosemide in the treatment of ascites in cirrhotic patients].
    Marelli A; Bodini P; Reggiani A; Quinzani M; Dizioli P; Tonghini L
    Minerva Med; 1997 Mar; 88(3):109-15. PubMed ID: 9148226
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical trial of bumetanide versus furosemide in patients with congestive heart failure.
    Konecke LL
    J Clin Pharmacol; 1981; 21(11):688-90. PubMed ID: 7040496
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Furosemide-induced natriuresis as a test to identify cirrhotic patients with refractory ascites.
    Spahr L; Villeneuve JP; Tran HK; Pomier-Layrargues G
    Hepatology; 2001 Jan; 33(1):28-31. PubMed ID: 11124817
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.